Target Name: MIR6800
NCBI ID: G102465480
Review Report on MIR6800 Target / Biomarker Content of Review Report on MIR6800 Target / Biomarker
MIR6800
Other Name(s): hsa-miR-6800-3p | hsa-mir-6800 | MicroRNA 6800 | hsa-miR-6800-5p | microRNA 6800

MIR6800: A Potential Drug Target or Biomarker for Diseases

MIR6800, also known as hsa-miR-6800-3p, is a non-coding RNA molecule that has been identified as a potential drug target or biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

MIR6800 is a microRNA (miRNA), a small non-coding RNA molecule that plays a critical role in regulating gene expression in cells. MiRNAs are made from a single RNA molecule, and they have been shown to play a crucial role in post-transcriptional gene regulation, by targetsing specific mRNAs for degradation or translation into protein.

The hsa-miR-6800 molecule was identified using bioinformatics analysis of gene expression data from various organisms, including humans. The molecule has been shown to be expressed in a variety of tissues and organs, including brain, heart, liver, and muscle.

One of the key features of MIR6800 is its length, which is approximately 29.8 nucleotides. This length allows for a large surface area and a high degree of flexibility in its interactions with other molecules.

MIR6800 has been shown to play a role in a variety of biological processes, including cell growth, apoptosis (programmed cell death), and autophagy (the process by which cells break down and recycle their own damaged or unnecessary components).

In addition to its role in cellular processes, MIR6800 has also been shown to play a role in diseases. For example, MIR6800 has been shown to be downregulated in various neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, and Huntington's disease. This suggests that MIR6800 may be a potential drug target or biomarker for these diseases.

In addition to its potential role in disease, MIR6800 has also been shown to be a potential drug target for cancer. For example, MIR6800 has been shown to be downregulated in various types of cancer, including breast cancer, lung cancer, and colon cancer. This suggests that MIR6800 may be a potential drug target or biomarker for these diseases.

Another potential application of MIR6800 is as a biomarker for monitoring disease progression. For example, MIR6800 has been shown to be downregulated in the brains of individuals with Alzheimer's disease, which suggests that MIR6800 may be a potential biomarker for Alzheimer's disease.

In conclusion, MIR6800 is a non-coding RNA molecule that has been identified as a potential drug target or biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Further research is needed to fully understand the role of MIR6800 in these diseases, as well as its potential as a drug target or biomarker.

Protein Name: MicroRNA 6800

The "MIR6800 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR6800 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MIR6801 | MIR6802 | MIR6803 | MIR6804 | MIR6805 | MIR6806 | MIR6807 | MIR6808 | MIR6809 | MIR6810 | MIR6811 | MIR6812 | MIR6813 | MIR6814 | MIR6815 | MIR6816 | MIR6817 | MIR6818 | MIR6819 | MIR6820 | MIR6821 | MIR6822 | MIR6823 | MIR6824 | MIR6825 | MIR6826 | MIR6827 | MIR6828 | MIR6829 | MIR6830 | MIR6831 | MIR6832 | MIR6833 | MIR6834 | MIR6836 | MIR6837 | MIR6839 | MIR6840 | MIR6841 | MIR6842 | MIR6843 | MIR6844 | MIR6845 | MIR6846 | MIR6847 | MIR6848 | MIR6849 | MIR6850 | MIR6851 | MIR6852 | MIR6853 | MIR6854 | MIR6855 | MIR6856 | MIR6857 | MIR6858 | MIR6859-1 | MIR6859-2 | MIR6859-3 | MIR6859-4 | MIR6860 | MIR6861 | MIR6862-1 | MIR6862-2 | MIR6863 | MIR6864 | MIR6865 | MIR6866 | MIR6867 | MIR6868 | MIR6869 | MIR6870 | MIR6871 | MIR6872 | MIR6873 | MIR6874 | MIR6875 | MIR6876 | MIR6877 | MIR6878 | MIR6879 | MIR6880 | MIR6881 | MIR6882 | MIR6883 | MIR6884 | MIR6885 | MIR6886 | MIR6887 | MIR6888 | MIR6889 | MIR6890 | MIR6891 | MIR6892 | MIR6893 | MIR6894 | MIR6895 | MIR7-1 | MIR7-2 | MIR7-3